Your browser is no longer supported. Please, upgrade your browser.
PCVX [NASD]
Vaxcyte, Inc.
Index- P/E- EPS (ttm)- Insider Own1.50% Shs Outstand50.90M Perf Week-0.04%
Market Cap1.41B Forward P/E- EPS next Y-2.58 Insider Trans-63.82% Shs Float41.85M Perf Month4.32%
Income- PEG- EPS next Q-0.54 Inst Own89.70% Short Float8.02% Perf Quarter-19.53%
Sales- P/S- EPS this Y-70.50% Inst Trans4.16% Short Ratio9.10 Perf Half Y-42.95%
Book/sh7.15 P/B3.61 EPS next Y59.20% ROA- Target Price- Perf Year-
Cash/sh7.29 P/C3.55 EPS next 5Y11.80% ROE- 52W Range17.80 - 58.47 Perf YTD-2.79%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-55.83% Beta-
Dividend %- Quick Ratio10.10 Sales past 5Y- Gross Margin- 52W Low45.11% ATR1.94
Employees43 Current Ratio10.10 Sales Q/Q- Oper. Margin- RSI (14)50.15 Volatility8.23% 7.89%
OptionableNo Debt/Eq0.00 EPS Q/Q85.70% Profit Margin- Rel Volume0.95 Prev Close25.94
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume368.84K Price25.83
Recom1.60 SMA201.02% SMA50-1.92% SMA200-26.64% Volume351,794 Change-0.42%
Jul-07-20Initiated Needham Buy $40
Jul-07-20Initiated Cantor Fitzgerald Overweight $55
Jul-07-20Initiated BofA Securities Buy $37
Jan-06-21 08:15AM  
Dec-22-20 08:00AM  
Dec-10-20 06:34PM  
Nov-24-20 04:05PM  
Nov-12-20 04:15PM  
Nov-10-20 04:41PM  
Sep-23-20 07:00AM  
Sep-14-20 02:27PM  
Sep-09-20 05:28PM  
Aug-14-20 03:01PM  
Aug-12-20 04:59PM  
04:10PM  
Jun-16-20 04:05PM  
Jun-12-20 11:24AM  
06:18AM  
01:06AM  
Jun-03-20 08:30AM  
May-21-20 08:30AM  
Vaxcyte, Inc., a preclinical-stage biotechnology vaccine company, develops vaccines to prevent or treat infectious diseases worldwide. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine. The company also develops VAX-XP to protect against emerging strains causing significant invasive pneumococcal disease and antibiotic resistance; VAX-A1, a conjugate vaccine candidate for protection against subtypes of Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting porphyromonas gingivalis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was founded in 2013 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fairman JeffVP, ResearchFeb 26Option Exercise0.044,7501906,158Mar 02 05:37 PM
Fairman JeffVP, ResearchFeb 26Sale23.934,750113,6631,408Mar 02 05:37 PM
PICKERING GRANTPresident & CEOFeb 22Option Exercise1.7915,00026,850593,691Feb 24 04:23 PM
Wassil JimChief Operating OfficerFeb 22Option Exercise2.423,0007,26019,381Feb 24 04:25 PM
Wassil JimChief Operating OfficerFeb 22Sale26.773,00080,29916,381Feb 24 04:25 PM
PICKERING GRANTPresident & CEOFeb 22Sale26.4715,000397,036578,691Feb 24 04:23 PM
Wright-Mitchell JaneGeneral CounselFeb 16Option Exercise2.032,5005,0754,062Feb 17 04:55 PM
Wright-Mitchell JaneGeneral CounselFeb 16Sale26.952,50067,3751,562Feb 17 04:55 PM
Sauer PaulSVP Process Dev, ManufacturingFeb 11Option Exercise1.792,5004,47580,399Feb 16 07:46 PM
Sauer PaulSVP Process Dev, ManufacturingFeb 11Sale26.652,50066,62477,899Feb 16 07:46 PM
Hopfner Robert LorneDirectorFeb 10Sale26.5378,1582,073,6581,405,418Feb 10 07:22 PM
Hopfner Robert LorneDirectorFeb 09Sale28.19220,7446,223,6921,483,576Feb 10 07:22 PM
Hopfner Robert LorneDirectorFeb 08Sale25.7979,7962,058,1171,704,320Feb 10 07:22 PM
Hopfner Robert LorneDirectorFeb 03Sale25.062,76869,3661,784,116Feb 04 08:51 PM
Hopfner Robert LorneDirectorFeb 02Sale25.1314,234357,7001,786,884Feb 04 08:51 PM
Hopfner Robert LorneDirectorJan 28Sale25.072,00050,1401,801,118Feb 02 12:17 PM
Hopfner Robert LorneDirectorJan 27Sale25.302,14054,1421,803,118Jan 27 06:02 PM
Fairman JeffVP, ResearchJan 26Option Exercise0.044,7501906,158Jan 28 04:36 PM
Fairman JeffVP, ResearchJan 26Sale25.274,750120,0151,408Jan 28 04:36 PM
Hopfner Robert LorneDirectorJan 26Sale25.3018,142458,9581,805,258Jan 27 06:02 PM
Hopfner Robert LorneDirectorJan 25Sale25.8134,972902,7451,823,400Jan 27 06:02 PM
Hopfner Robert LorneDirectorJan 22Sale25.1611,383286,3961,858,372Jan 22 06:10 PM
Hopfner Robert LorneDirectorJan 21Sale25.111002,5111,869,755Jan 22 06:10 PM
Wassil JimChief Operating OfficerJan 20Option Exercise2.423,0007,26019,381Jan 21 07:12 PM
Wassil JimChief Operating OfficerJan 20Sale25.503,00076,50016,381Jan 21 07:12 PM
Hopfner Robert LorneDirectorJan 20Sale25.3519,046482,8161,869,855Jan 22 06:10 PM
PICKERING GRANTPresident & CEOJan 19Option Exercise1.7915,00026,850593,691Jan 21 06:58 PM
PICKERING GRANTPresident & CEOJan 19Sale25.1015,000376,498578,691Jan 21 06:58 PM
Hopfner Robert LorneDirectorJan 19Sale25.6249,5161,268,6341,888,901Jan 19 09:07 PM
Wright-Mitchell JaneGeneral CounselJan 15Option Exercise2.032,5005,0754,062Jan 19 06:29 PM
Hopfner Robert LorneDirectorJan 15Sale25.7826,677687,8461,938,417Jan 19 09:07 PM
Wright-Mitchell JaneGeneral CounselJan 15Sale26.002,50065,0001,562Jan 19 06:29 PM
Hopfner Robert LorneDirectorJan 14Sale25.8814,918386,0781,965,094Jan 19 09:07 PM
Hopfner Robert LorneDirectorJan 13Sale25.9529,110755,3131,980,012Jan 13 08:39 PM
Hopfner Robert LorneDirectorJan 12Sale26.3818,567489,8712,009,122Jan 13 08:39 PM
Sauer PaulSVP Process Dev, ManufacturingJan 11Option Exercise1.792,5004,47580,399Jan 12 09:43 PM
Hopfner Robert LorneDirectorJan 11Sale26.4549,6661,313,7642,027,689Jan 13 08:39 PM
Sauer PaulSVP Process Dev, ManufacturingJan 11Sale26.212,50065,52777,899Jan 12 09:43 PM
Hopfner Robert LorneDirectorJan 08Sale26.5840,6121,079,5492,077,355Jan 08 05:17 PM
Hopfner Robert LorneDirectorJan 07Sale28.2747,5801,344,8872,117,967Jan 08 05:17 PM
Hopfner Robert LorneDirectorJan 06Sale29.5357,4201,695,8412,165,547Jan 08 05:17 PM
Fairman JeffVP, ResearchDec 29Option Exercise1.797401,3251,408Dec 30 08:26 PM
PICKERING GRANTPresident & CEODec 28Option Exercise1.795,5009,845578,691Dec 29 06:01 PM
PICKERING GRANTPresident & CEODec 21Option Exercise1.7915,00026,850588,191Dec 22 08:44 PM
PICKERING GRANTPresident & CEODec 21Sale28.8815,000433,141573,191Dec 22 08:44 PM
TPG Group Holdings (SBS) AdvisFormer 10% OwnerDec 15Sale32.5081,9792,664,6915,074,574Dec 17 07:13 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerOct 08Sale50.69167,6618,498,0655,001,593Oct 09 04:22 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerOct 07Sale50.9598,5975,023,5275,169,254Oct 09 04:22 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerSep 30Sale50.27124,6566,265,8715,283,818Oct 01 05:25 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerSep 29Sale52.0880,7074,202,9875,408,474Oct 01 05:25 PM